{{Rsnum
|rsid=6859974
|Chromosome=5
|position=180778938
|Orientation=plus
|GMAF=0.3609
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 75.0 | 23.4 | 1.6
| HCB | 51.1 | 39.4 | 9.5
| JPT | 52.2 | 32.7 | 15.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 51.1 | 39.4 | 9.5
| CHD | 56.0 | 33.9 | 10.1
| GIH | 47.5 | 28.7 | 23.8
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 32.0 | 30.7 | 37.3
| TSI | 73.5 | 18.6 | 7.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=T
  |Pval=8E-6
  |OR=3.67
  |ORtxt=[2.06-5.28] mg/dL increase
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}